These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32555112)
1. Minocycline foam (Amzeeq) for acne. Med Lett Drugs Ther; 2020 May; 62(1597):68-70. PubMed ID: 32555112 [No Abstract] [Full Text] [Related]
2. Drugs for acne. Med Lett Drugs Ther; 2020 Nov; 62(1612):188-191. PubMed ID: 33443492 [No Abstract] [Full Text] [Related]
3. Drugs for acne. Med Lett Drugs Ther; 2024 Feb; 66(1695):17-20. PubMed ID: 38294764 [No Abstract] [Full Text] [Related]
4. Sarecycline (Seysara) - another oral tetracycline for acne. Med Lett Drugs Ther; 2019 Mar; 61(1568):43-44. PubMed ID: 31022156 [No Abstract] [Full Text] [Related]
5. Clascoterone cream (Winlevi) for acne. Med Lett Drugs Ther; 2021 Dec; 63(1640):202-204. PubMed ID: 35100239 [No Abstract] [Full Text] [Related]
6. Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris. Gupta AK; Bruce A; Vincent KD; Abramovits W Skinmed; 2020; 18(6):354-357. PubMed ID: 33397564 [No Abstract] [Full Text] [Related]
7. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555 [TBL] [Abstract][Full Text] [Related]
8. Minocycline Topical Foam: A New Drug for the Treatment of Acne. Onge ES; Mobley WC Ann Pharmacother; 2021 Jan; 55(1):105-110. PubMed ID: 32618475 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne. Jones TM; Ellman H; deVries T J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256 [TBL] [Abstract][Full Text] [Related]
11. Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results. Shemer A; Shiri J; Mashiah J; Farhi R; Gupta AK J Am Acad Dermatol; 2016 Jun; 74(6):1251-2. PubMed ID: 27185426 [No Abstract] [Full Text] [Related]
12. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176 [TBL] [Abstract][Full Text] [Related]
13. Topical Minocycline Foam 4%: A Review in Acne Vulgaris. Paik J Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355 [TBL] [Abstract][Full Text] [Related]
14. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805 [TBL] [Abstract][Full Text] [Related]
15. Evaluating FMX-101 as a promising therapeutic for the treatment of acne. Valente Duarte de Sousa IC Expert Opin Pharmacother; 2020 May; 21(7):741-746. PubMed ID: 32037906 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study. Raoof TJ; Hooper D; Moore A; Zaiac M; Sullivan T; Kircik L; Lain E; Jankicevic J; Stuart I J Am Acad Dermatol; 2020 Apr; 82(4):832-837. PubMed ID: 31163231 [TBL] [Abstract][Full Text] [Related]
17. Combination topical therapy in the treatment of acne. Del Rosso JQ Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494 [TBL] [Abstract][Full Text] [Related]
19. Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne. McKeage K; Keating GM Am J Clin Dermatol; 2008; 9(3):193-204. PubMed ID: 18429651 [TBL] [Abstract][Full Text] [Related]